Stavrogianni, K.; Kitsos, D.K.; Giannopapas, V.; Smyrni, V.; Chasiotis, A.K.; Akrivaki, A.; Dimitriadou, E.-M.; Zompola, C.; Tzartos, J.S.; Tsivgoulis, G.;
et al. Evaluating Vaporized Cannabinoid Therapy in Multiple Sclerosis: Findings from a Prospective Single-Center Clinical Study. J. Clin. Med. 2025, 14, 2121.
https://doi.org/10.3390/jcm14062121
AMA Style
Stavrogianni K, Kitsos DK, Giannopapas V, Smyrni V, Chasiotis AK, Akrivaki A, Dimitriadou E-M, Zompola C, Tzartos JS, Tsivgoulis G,
et al. Evaluating Vaporized Cannabinoid Therapy in Multiple Sclerosis: Findings from a Prospective Single-Center Clinical Study. Journal of Clinical Medicine. 2025; 14(6):2121.
https://doi.org/10.3390/jcm14062121
Chicago/Turabian Style
Stavrogianni, Konstantina, Dimitrios K. Kitsos, Vasileios Giannopapas, Vassiliki Smyrni, Athanasios K. Chasiotis, Alexandra Akrivaki, Evangelia-Makrina Dimitriadou, Christina Zompola, John S. Tzartos, Georgios Tsivgoulis,
and et al. 2025. "Evaluating Vaporized Cannabinoid Therapy in Multiple Sclerosis: Findings from a Prospective Single-Center Clinical Study" Journal of Clinical Medicine 14, no. 6: 2121.
https://doi.org/10.3390/jcm14062121
APA Style
Stavrogianni, K., Kitsos, D. K., Giannopapas, V., Smyrni, V., Chasiotis, A. K., Akrivaki, A., Dimitriadou, E.-M., Zompola, C., Tzartos, J. S., Tsivgoulis, G., & Giannopoulos, S.
(2025). Evaluating Vaporized Cannabinoid Therapy in Multiple Sclerosis: Findings from a Prospective Single-Center Clinical Study. Journal of Clinical Medicine, 14(6), 2121.
https://doi.org/10.3390/jcm14062121
